SG/CALL/FRESENIUS MEDICAL CARE/32/0.1/21.06.24 Stock

Warrant

DE000SQ71SE8

Delayed Deutsche Boerse AG 04:59:58 2024-05-29 EDT
0.67 EUR -6.94% Intraday chart for SG/CALL/FRESENIUS MEDICAL CARE/32/0.1/21.06.24
Current month-2.70%
1 month+24.14%
Date Price Change
24-05-29 0.67 -6.94%
24-05-28 0.72 +5.88%
24-05-27 0.68 -2.86%
24-05-24 0.7 +12.90%
24-05-23 0.62 -8.82%

Delayed Quote Deutsche Boerse AG

Last update May 29, 2024 at 04:59 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Société Générale Société Générale
WKN SQ71SE
ISINDE000SQ71SE8
Date issued 2023-01-17
Strike 32
Maturity 2024-06-21 (24 Days)
Parity 10 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.93
Lowest since issue 0.33
Spread 0.02
Spread %2.90%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.32 EUR
Average target price
39.84 EUR
Spread / Average Target
+1.33%
Consensus